Last updated 2026-07-27
- Acquired by Johnson & Johnson for $438M, Dec 2008
- Raised $4.8M Undisclosed Round led by Catalyst, Feb 2005
- Raised Follow-on PO, Dec 2004
Total raised
$4.8M
Last: Undisclosed Round 2005-03
Stage
Acquired
Founded
1995
Headcount
270
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Omrix Biopharmaceuticals specializes in the development and manufacture of life-saving products based on human plasma. The company's biosurgery product line includes hemostatic products designed to control bleeding during surgery, and its passive immunotherapy product line offers antibody-rich products for immune deficiencies and infectious diseases. Omrix operates as part of Johnson & Johnson's Medical Device and Diagnostics Sector, reporting through Ethicon Inc. The company has facilities including a production plant at Tel Hashomer Hospital, a biomanufacturing facility in Har-Hozvim Technology Park, Jerusalem, and an R&D facility located in the Weizmann Science Park of Ness Ziona.
Funding history · 2 rounds · $4.8M total
2005-02
Undisclosed Round
$4.8M
★ Catalyst★ Hercules Capital, Inc.
2004-12
Follow-on PO
Undisclosed
Headcount over time
From 303 (2023-11) to 273 (2026-03) · -30 (-10%) · 13 points · source: Finder history + radar grounding
Q&A
- What is Omrix Biopharmaceuticals' primary focus?
- Omrix Biopharmaceuticals specializes in the development and manufacture of protein-based biosurgery and passive immunotherapy products derived from human plasma.
- When was Omrix Biopharmaceuticals acquired and by whom?
- Omrix Biopharmaceuticals was acquired by Johnson & Johnson in December 2008 for $438,000,000.
- What is the current employee count for Omrix Biopharmaceuticals?
- Omrix Biopharmaceuticals has 270 employees, falling within the 201-500 employee bucket.
- Where are Omrix Biopharmaceuticals' main facilities located?
- Omrix Biopharmaceuticals has a production plant at Tel Hashomer Hospital, a biomanufacturing facility in Har-Hozvim Technology Park, Jerusalem, and an R&D facility in the Weizmann Science Park of Ness Ziona.
- What was the amount raised in Omrix Biopharmaceuticals' Public Offering in 2006?
- In 2006, Omrix Biopharmaceuticals raised $80,500,000 in a Public Offering, with UBS and CIBC as lead investors.
- Who founded Omrix Biopharmaceuticals?
- Omrix Biopharmaceuticals was founded by Robert Taub.
- What type of products does Omrix Biopharmaceuticals offer in its biosurgery line?
- Omrix Biopharmaceuticals' biosurgery product line includes hemostatic products designed to control bleeding during surgery.
- What was the total amount of funding raised by Omrix Biopharmaceuticals before its acquisition?
- Omrix Biopharmaceuticals raised a total of $87,500,000 in funding.
Team · 1
Robert Taub
Founder · Founder and CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersMedical Devices IndustryMedical Products
Business model
B2B
Highlights
1 Patents
Tags
surgeryimmunologymedical-productsbiotechnologypharmaceuticalsbiopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | omrix-careers.com/ |
|---|---|
| linkedin.com/company/52855 |
Identifiers & details
| Legal name | Omrix Biopharmaceuticals Inc. |
|---|---|
| Founded | 1995 |
| Employees (exact) | 270 |
| Status reason | Acquired (Inactive) by Johnson & Johnson on Nov 2008 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Johnson & Johnson 2008-12 $438.0M
Radar intelligence
Patents
| EPO | 108 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512166059 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1995-06-21 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — other (1), annual_report (4) |
| Registered address | אינשטיין 14 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-24 | עדכון כתובת ו/או מען דיגיטלי |
| 2025-11-05 | דו~ח שנתי-הוספת בעל תפקיד |
| 2025-11-05 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2025-11-05 | דו~ח שנתי-עדכון תחום עיסוק |
| 2025-11-05 | דו~ח שנתי-עדכון מען דיגיטלי |